STXS insider trading

NYSE American Healthcare

Stereotaxis, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
272
Last 90 days
1
Buys / sells
19% / 13%
Market cap
$199.71M

About Stereotaxis, Inc.

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN, which is designed to enhance the accessibility of RMN by eliminating the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; V-CAS; and MAGiC catheter for cardiac ablation procedures. Further, it provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

Company website: www.stereotaxis.com

STXS insider activity at a glance

FilingIQ has scored 272 insider transactions for STXS since Mar 13, 2015. The most recent filing in our index is dated Apr 11, 2026.

Across the full history, 53 open-market purchases and 34 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on STXS insider trades is 46.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Other Healthcare tickers with recent insider activity

Frequently asked

How many insider trades does FilingIQ track for STXS?
FilingIQ tracks 272 Form 4 insider transactions for STXS (Stereotaxis, Inc.), covering filings from Mar 13, 2015 onwards. 1 of those were filed in the last 90 days.
Are STXS insiders net buyers or net sellers?
Across the full Form 4 history for STXS, 53 transactions (19%) were open-market purchases and 34 (13%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does STXS insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is STXS in?
Stereotaxis, Inc. (STXS) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $199.71M.

Methodology & sources

Every STXS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.